Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time.

@article{Ryu2009GinkgoBE,
  title={Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time.},
  author={Keun Ho Ryu and Hye Young Han and So Young Lee and Sun Duck Jeon and Guang-jin Im and Bongyong Lee and Keunyoung Kim and Kyung-Min Lim and Jin Ho Chung},
  journal={Thrombosis research},
  year={2009},
  volume={124 3},
  pages={
          328-34
        }
}
View on PubMed
doi.org
89 Citations
Highly Influential Citations
1
Background Citations
25
Methods Citations
4
Results Citations
2

Figures from this paper

89 Citations

Antiplatelet, Antithrombotic, and Fibrinolytic Activities of Campomanesia xanthocarpa

Investigating the effects of C. xanthocarpa extract on antiplatelet, antithrombotic and fibrinolytic activities in mice and in human blood demonstrated that CXE has a significant protective effect on thrombosis.

Antiplatelet and Antithrombotic Effects of the Extract of Lindera obtusiloba Leaves

Results suggest that LLE may be a candidate preventive and therapeutic agent in cardiovascular diseases associated with platelet hyperactivity, and indicates that the antithrombotic effects of LLE might be due to its antiplatelet activities rather than anticoagulation.

Ticlopidine with Ginkgo Biloba extract: a feasible combination for patients with acute cerebral ischemia.

Chloroform fraction of Euphorbia maculata has antiplatelet activity via suppressing thromboxane B2 formation.

Results suggest that CFEM exhibits antiplatelet activity, without causing bleeding, via the suppression of TXB2 formation, which may be a type of food which has the potential for preventing cardiovascular disease.

Antithrombotic and Antiplatelet Effects of Cordyceps militaris

Results suggest that antithrombotic activity of CMEE is related to antiplatelet effect rather than anticoagulation effect, and CMEE may be a positive effect on improving blood circulation against vessel injury and occlusion.

Antithrombotic potential of plant products

The analysis of the characteristic features of the antiplatelet effects of different products derived from Allium sativum, Ginkgo biloba, Sacharum officinarum, Theobroma cacao, and Vitis vinifera suggest that antithrombotic potentials could be found in medicinal plants traditionally used to treat inflammation, bronchitis,Bronchial asthma and vascular disorders.

Antithrombotic activity of Vitis labrusca extract on rat platelet aggregation

The results indicate that VLE possesses antiplatelet activity via the suppression of TXB2 and serotonin, without affecting bleeding, and VLE may be a potential agent for the prevention of cardiovascular diseases.

In Vitro Antiplatelet Aggregation Activity of Centella asiatica ( L . ) Urban Ethanolic Extract

In vitro study of antiplatelet aggregation of Centella asiatica ethanolic extract showed that both of pCEE and npCEE had anti-platelets aggregation activity on the range concentration of 200, 400, and 800 μg/ml, however, anti platelet aggregation activity of p CEE and n-hexane purified CEE were not different statistically.

Antiplatelet and antithrombotic effect of Phyllostachys pubescens leaves and Mume Fructus combination

It is suggested that combination preparations of PL and MF, especially their 2:1 combination, can increase antiplatelet and antithromboticeffects more than PL andMF alone, offering evidence for a potential novel combination antithromabotic therapy.

Inhibitory effect of Campomanesia xanthocarpa in platelet aggregation: Comparison and synergism with acetylsalicylic acid.

...

30 References

Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761).

Interaction Potential and Tolerability of the Coadministration of Cilostazol and Aspirin

Cilostazol and aspirin coadministration did not cause clinically significant changes in PT, aPTT, bleeding time, platelet aggregation or plasma concentrations of cilostrazol and its 2 active metabolites.

Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects.

Cilostazol as a unique antithrombotic agent.

The unique properties of CLZ are reviewed with the focus on CLZ as a unique antiplatelet agent targeting platelets and VSMC, demonstrating synergy with endogenous mediators and showing lowered risk of bleeding risk compared to other antiplatelets drugs.

Inhibitory effect of Ginkgo biloba extract on human platelet aggregation.

GBE is a mixture of many compounds, including flavonoids and gingkoglides, which affect metabolism of cAMP, TxA(2) and Ca2+ in platelets, and thus may be potentially used as an effective oral anti-platelet therapeutic agent.

New antiplatelet strategies in atherothrombosis and their indications.

  • P. FontanaJ. Reny
  • Biology, Medicine
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  • 2007

Mouse antithrombotic assay: the effects of Ca++ channel blockers are platelet-independent.

The data suggest that Ca++ channel blockers reduce the mortality in the Mouse Antithrombotic Assay by influencing factors other than platelet aggregation and/or Tx production.

Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.

Elevation of interstitial and circulating adenosine levels by cilostazol has been found to potentiate the cAMP-elevating effect of PDE3 inhibition in platelets and smooth muscle, thereby augmenting antiplatelet and vasodilatory effects of the drug.

Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP- and cGMP-dependent manner by activated MMP-9.

Results strongly indicate that activated MMP-9 is a potent inhibitor of collagen-stimulated platelet aggregation and may act a crucial role as a negative regulator during platelet activation.

Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

Ginkgo and ginger at recommended doses do not significantly affect clotting status, the pharmacokinetics or pharmacodynamics of warfarin in healthy subjects and these herbs did not affect CYP2C9 activity.